sever
acut
respiratori
syndrom
coronaviru
spread
across
pseudotyp
particl
neutral
assay
authent
neutral
assay
competit
ligandbind
data
suggest
sdab
either
complet
block
significantli
inhibit
associ
rbd
viral
entri
receptor
final
show
fusion
human
fc
sdab
improv
neutral
activ
ten
time
result
reveal
novel
rbd
target
sdab
pave
road
antibodi
drug
develop
coronaviru
diseas
caus
infect
emerg
sever
acut
respiratori
syndromeassoci
coronaviru
declar
world
health
organ
first
coronaviru
pandem
human
histori
sever
symptom
rang
asymptomat
mild
sever
estim
mortal
rate
less
patient
depend
variou
factor
spread
rapidli
sustain
around
world
urg
prompt
global
action
develop
vaccin
antivir
therapeut
polyprotein
share
ident
sarscov
genbank
id
coronavirida
envelop
positivesens
singlestrand
rna
viru
larg
genom
approxim
nucleotid
length
virusencod
membran
spike
envelop
e
protein
constitut
major
protein
incorpor
envelop
lipid
bilay
protein
form
homotrim
protrud
envelop
show
coron
appear
invad
suscept
cell
bind
potenti
entri
receptor
angiotensin
convert
enzym
recent
research
figur
molecular
structur
protein
compos
amino
acid
structur
belong
type
membran
fusion
protein
two
area
region
mainli
includ
receptor
bind
domain
rbd
region
necessari
membran
fusion
rbd
structur
determin
bind
effici
provid
import
target
neutral
antibodi
recognit
singl
domain
antibodi
sdab
name
nanobodi
initi
identifi
camelid
cartilagin
fish
heavychain
antibodi
devoid
light
chain
antigenbind
mediat
exclus
singl
variabl
domain
vhh
therefor
sdab
smallest
fragment
retain
full
antigenbind
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
capac
antibodi
advantag
properti
drug
imag
probe
diagnost
reagent
advantag
short
develop
time
flexibl
format
robust
product
effici
make
sdab
power
mean
defeat
infecti
diseas
pandem
therapeut
purpos
rel
sophist
human
techniqu
adopt
modifi
camelidspecif
amino
acid
sequenc
framework
human
heavi
chain
variabl
domain
equival
without
alter
sdab
biolog
physic
properti
reduc
speci
heterogen
emerg
human
viru
whole
popul
suscept
due
lack
protect
antibodi
exist
neutral
antibodi
convalesc
plasma
adopt
power
therapeut
altern
patient
china
use
synthet
human
sdab
discoveri
platform
abl
obtain
sever
highaffin
rbd
target
sdab
desir
neutral
activ
result
make
use
envelop
glycoprotein
gain
entri
host
cell
bind
recent
cryoem
research
reveal
protein
show
asymmetr
homotrim
singl
rbd
confirm
two
antibodi
may
take
advantag
rbd
structur
block
viru
entri
enrich
rbd
bind
sdab
perform
four
round
biopan
use
lab
own
full
synthet
human
phage
display
librari
recombin
rbd
protein
phage
elisa
identif
clone
number
sdab
exhibit
excel
affin
rbd
five
distinct
sdad
sequenc
clone
prokaryot
express
vector
recombin
sdab
protein
purifi
nickelcharg
sepharos
affin
chromatographi
fig
human
sdab
obtain
studi
amino
acid
singl
vhh
domain
averag
molecular
weight
less
fig
sdab
consist
three
complementar
determin
region
cdr
well
four
framework
region
fr
amino
acid
framework
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
maxim
human
except
residu
maintain
proper
antigen
affin
best
stabil
surfac
plasmon
reson
spr
technolog
wide
accept
golden
standard
character
antibodyantigen
interact
determin
kinet
rate
affin
constant
detail
analysi
antigenbind
purifi
sdab
protein
carri
spr
sarccov
protein
immobil
surfac
biacor
chip
respect
variou
concentr
purifi
sdab
prepar
inject
pass
surfac
sensorgram
data
fit
steadyst
bind
model
spr
result
demonstr
equilibrium
dissoci
constant
kd
protein
sdab
nm
nm
nm
nm
nm
respect
fig
howev
sdab
show
bind
sarscov
protein
except
clone
demonstr
rel
low
affin
kd
nm
fig
overal
monoval
antibodi
fragment
sdab
identifi
studi
reveal
satisfactori
bind
perform
specif
manner
evalu
neutral
activ
sdab
spseudotyp
particl
infect
assay
first
establish
pseudotyp
particl
chimer
virion
consist
surrog
viral
core
heterolog
viral
envelop
protein
surfac
oper
biosafeti
level
frequent
use
tool
studi
viru
entri
mechan
neutral
antibodi
observ
five
sdab
show
inhibit
potenc
infect
ic
half
maxim
inhibitori
concentr
rang
fig
next
test
neutral
activ
sdab
live
viru
fig
similarli
sdab
show
compar
neutral
effici
ic
approxim
total
monoval
sdab
demonstr
encourag
neutral
activ
pseudotyp
authent
viru
although
neutral
potenc
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
complet
match
fig
phenomenon
normal
report
middl
east
respiratori
syndrom
coronaviru
merscov
neutral
antibodi
may
like
explain
differ
sdab
recogn
rbd
spatial
epitop
steric
hindranc
form
antigenantibodi
complex
within
rbd
receptor
bind
motif
rbm
directli
contact
recent
report
demonstr
use
receptor
much
stronger
affin
higher
sarscov
determin
whether
sdab
target
differ
antigen
region
rbd
surfac
perform
competitionbind
assay
use
realtim
biosensor
fig
test
five
sdab
competitionbind
assay
human
attach
biosensor
compar
nonrel
isotyp
control
sdab
fig
addit
complet
prevent
bind
rbd
fig
wherea
sdab
could
partial
compet
rbdreceptor
associ
fig
data
suggest
sdab
divid
rbm
target
nonrbm
target
group
though
directli
associ
viru
neutral
activ
sdab
readili
fuse
human
fcdomain
overcom
limit
monoval
sdab
short
blood
residenti
time
lack
antibodydepend
cellmedi
cytotox
complement
depend
cytotox
addit
bival
sdab
obtain
via
disulfid
bond
format
fc
hing
area
report
significantli
increas
sdab
activ
explor
possibl
sdabbas
antivir
therapeut
enhanc
neutral
activ
construct
human
heavi
chain
antibodi
fuse
human
fc
region
cterminu
sdab
fig
fc
fusion
sdab
produc
mammalian
cell
suspens
yield
around
per
millilit
shake
flask
supernat
sampl
analyz
reduc
nonreduc
condit
western
blot
use
antihuman
igg
detect
fc
shown
fig
size
construct
intact
sdabfc
around
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
kda
nonreduc
condit
kda
monom
observ
prior
treatment
reduc
condit
break
disulfid
bond
suggest
correct
express
secret
heavi
chain
antibodi
consist
design
neutral
assay
result
show
genet
fusion
human
fc
significantli
increas
neutral
activ
sdab
molar
concentr
ic
use
entri
assay
fig
importantli
sever
fcfuse
sdab
demonstr
potenc
ic
subnanomolar
level
fig
final
show
sdab
suitabl
immunofluoresc
stain
supplementari
fig
western
blot
detect
ectop
express
protein
supplementari
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
method
vero
african
green
monkey
kidney
human
kidney
epitheli
synthet
sdab
phage
display
librari
use
screen
neutral
antibodi
minim
possibl
antigen
effect
camelid
sequenc
sdab
framework
librari
construct
determin
accord
univers
human
scaffold
architectur
briefli
residu
frame
mutat
base
human
heavi
chain
vh
maximum
frame
human
residu
posit
adopt
increas
stabil
sdab
wherea
residu
maintain
camelid
due
critic
impact
antigen
affin
andor
stabil
design
variabl
region
analyz
robust
cdr
repertoir
immun
llama
vhh
clone
synthet
divers
introduc
three
cdr
random
nucleotid
incorpor
cystein
stop
codon
avoid
constant
length
amino
acid
select
amino
acid
framework
cdr
assembl
overlap
polymeras
chain
reaction
pcr
ensur
uniqu
cdr
recombin
assembl
molecul
diversifi
sdab
mixtur
clone
phagemid
vector
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antibodi
design
lab
san
diego
ca
usa
use
sfiibgli
site
pelb
peptid
leader
sequenc
fuse
sdab
nterminu
massiv
electropor
carri
use
e
coli
cell
thousand
agar
petri
dish
mm
plate
ensur
enough
size
librari
qualiti
control
carri
sequenc
clone
error
rate
divers
calcul
screen
rbd
target
antibodi
perform
pan
immunotub
nativ
condit
use
proprietari
fullsynthet
librari
human
sdab
highdivers
accord
standard
protocol
briefli
nd
th
pan
round
purifi
rbd
protein
coat
nunc
maxisorp
immuno
tube
thermofish
around
pb
overnight
absorb
measur
use
spectramax
plate
reader
molecular
divic
san
jose
ca
usa
posit
clone
sent
sequenc
repres
sdab
sequenc
chosen
protein
express
fulllength
sequenc
select
sdab
pcr
amplifi
clone
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ncoixhoi
site
novagen
sacramento
ca
usa
transform
chemic
compet
e
coli
singl
coloni
pick
inocul
ml
lb
media
contain
kanamycin
incub
orbit
shaker
overnight
precultur
dilut
ml
lb
media
contain
kanamycin
grown
od
nm
reach
express
recombin
sdab
induc
ad
iptg
final
concentr
mm
cultur
reach
od
grown
night
sdab
histag
fuse
cterminu
purifi
ni
bind
affin
assay
sarscov
protein
dilut
sodium
acet
buffer
immobil
chip
respons
unit
antibodi
gradient
concentr
flow
chip
surfac
cycl
sensor
surfac
regener
glycinehcl
ph
data
fit
interact
steadyst
bind
model
use
biaevalu
softwar
competitionbind
assay
protein
dilut
sodium
acet
buffer
immobil
chip
respons
unit
analys
rbd
protein
dilut
hbsep
buffer
hbsep
buffer
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antibodi
rbd
differ
buffer
gradient
concentr
flow
chip
surfac
cycl
sensor
surfac
regener
glycinehcl
ph
bind
kinet
analyz
softwar
biaevalu
use
bind
product
spike
pseudotyp
particl
viru
entri
assay
produc
cell
seed
day
prior
transfect
cell
plate
next
day
cell
transfect
use
lipofectamin
thermofish
plasmid
dna
transfect
mixtur
ml
compos
rand
purchas
sino
biolog
reconstruct
delet
amino
acid
cytoplasm
tail
nonenvelop
lentiviru
particl
bald
viru
also
gener
neg
control
sixteen
hour
transfect
media
replac
fresh
media
supplement
fb
supernat
contain
typic
harvest
h
transfect
filter
syring
filter
typic
rel
luminomet
unit
conduct
viru
entri
assay
vero
cell
seed
plate
day
prior
transduct
next
day
supernat
contain
ad
well
absenc
presenc
serial
dilut
sdab
human
fcfuse
sdab
fortyeight
hour
transduct
cell
lyse
passiv
lysi
buffer
lysat
incub
luciferas
assay
substrat
accord
manufactur
instruct
promega
madison
wi
usa
isol
bronchoalveolar
lavag
specimen
patient
describ
previous
viral
titer
determin
use
tissu
cultur
infect
dose
antibodi
neutral
assay
vero
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
seed
plate
day
prior
infect
serial
dilut
sdab
mix
multipl
infect
moi
incub
antibodyviru
mixtur
incub
vero
cell
unbound
produc
fcfusion
protein
analyz
sdspage
western
blot
use
standard
protocol
dimer
yield
puriti
measur
primari
antibodi
use
western
blot
horseradish
peroxidas
conjug
goat
antimous
igg
sigmaaldrich
st
loui
mo
usa
cultur
cell
coverslip
transfect
either
express
plasmid
empti
vector
h
fix
use
paraformaldehyd
min
room
temperatur
permeabil
triton
sigmaaldrich
pb
min
cell
incub
sdab
overnight
three
wash
pb
cell
incub
alexa
fluor
tag
monoclon
antibodi
thermofish
hour
room
temperatur
nuclei
stain
dapi
dilut
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
pb
min
mount
antifad
reagent
thermofish
imag
acquir
leica
tc
confoc
microscop
system
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
